Keyphrases
Alcohol Use Disorder
54%
Risperidone
53%
Alcohol Dependence
36%
Alcohol
31%
Ghrelin
27%
Negative Symptoms
27%
Randomized Placebo-controlled Trial
26%
Adjunctive Therapy
26%
Alcohol Drinking
26%
Placebo
25%
Chronic Schizophrenia
24%
Negative Syndrome
22%
Heavy Drinking
21%
Randomized Double-blind Placebo-controlled Study
21%
Major Depressive Disorder
21%
Glucagon-like
19%
Ghrelin System
19%
Substance Use Disorder
18%
Alcohol Consumption
17%
Placebo-controlled
17%
Placebo Groups
17%
Subscale Scores
16%
Alcohol Use
16%
Human Laboratory Studies
15%
Schizophrenia
15%
Human Laboratory
15%
Alcohol Intake
15%
Abstinence
15%
Double-blind Placebo-controlled Trial
14%
Pioglitazone
14%
Placebo-controlled Randomized Trial
14%
Baclofen
14%
Pharmacotherapy
14%
Substance Use
13%
Autistic Disorder
12%
Ghrelin Level
12%
Randomized Double-blind
12%
Adjuvant Therapy
11%
Alcohol Administration
10%
Bipolar Disorder
10%
Pharmaceutics
10%
Childhood Autism
10%
Alcohol Use Disorder Treatment
10%
Negative Symptoms of Schizophrenia
10%
Aberrant Behavior Checklist
10%
Riluzole
9%
N-acetylcysteine
9%
Mineralocorticoid Receptor
9%
Agonism
9%
Neuroendocrine Response
9%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Ethanol
89%
Risperidone
52%
Negative Syndrome
33%
Ghrelin
29%
Placebo-Controlled Study
26%
Randomized Controlled Trial
23%
Schizophrenia
23%
Ghrelin Receptor
21%
Glucagon-Like Peptide-1
21%
Autism
17%
Positive Syndrome
16%
Baclofen
16%
Symptom
15%
Inverse Agonist
15%
Pioglitazone
14%
Pharmacotherapy
14%
Disease
14%
Combination Therapy
12%
Controlled Clinical Trial
12%
Major Depression
11%
Behavior Disorder
10%
4 Aminobutyric Acid
9%
Spironolactone
9%
Acetylcysteine
9%
Crocus Sativus
9%
Randomized Clinical Trial
9%
Riluzole
9%
Glucagon Like Peptide 1 Receptor Agonist
9%
Adverse Event
9%
Amylin
9%
Bipolar Disorder
8%
Tolerability
8%
Receptor
8%
Depression
8%
Acetylsalicylic Acid
7%
Clinical Trial
7%
Side Effect
7%
Mineralocorticoid Receptor
6%
Semaglutide
6%
Drug Dependence
6%
Cytokine
5%
Gastrointestinal Hormone
5%
Cohort Study
5%
Human Study
5%
Neuroscience
Placebo
65%
Alcohol Abuse
38%
Ghrelin
36%
Risperidone
31%
Randomized Controlled Trial
22%
Dementia Praecox
21%
Negative Syndrome
18%
Adjuvant Therapy
15%
Pervasive Developmental Disorder
14%
Physical Dependence
13%
Depression
13%
Glucagon-Like Peptide-1
13%
Mineralocorticoid Receptor
11%
Growth Hormone Secretagogue Receptor
11%
Bipolar Disorder
11%
Major Depressive Disorder
10%
Brain-Derived Neurotrophic Factor
9%
Riluzole
9%
Inverse Agonist
9%
Personality Traits
9%
Fibroblast Growth Factor 21
9%
Leptin
9%
Positive Syndrome
9%
Substance Abuse
8%
Female Rats
7%
Behavior (Neuroscience)
7%
C-Reactive Protein
7%
Receptor Gene
7%
Glucagon-Like Peptide 1 Receptor
7%
Opiate
7%
Amylin
6%
Hyperactivity
6%
Analeptic
6%
Psychostimulant
5%
Gastrointestinal Hormone
5%
